Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB. Teh BS, et al. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1520-9. doi: 10.1016/j.ijrobp.2003.09.083. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050332 Clinical Trial.
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Satoh T, Teh BS, Timme TL, Mai WY, Gdor Y, Kusaka N, Fujita T, Pramudji CK, Vlachaki MT, Ayala G, Wheeler T, Amato R, Miles BJ, Kadmon D, Butler EB, Thompson TC. Satoh T, et al. Among authors: miles bj. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):562-71. doi: 10.1016/j.ijrobp.2004.01.020. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145177 Clinical Trial.
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB. Tetzlaff MT, et al. Among authors: miles bj. Technol Cancer Res Treat. 2006 Feb;5(1):23-36. doi: 10.1177/153303460600500104. Technol Cancer Res Treat. 2006. PMID: 16417399 Free article. Review.
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D. Ayala G, et al. Among authors: miles bj. Mol Ther. 2006 Apr;13(4):716-28. doi: 10.1016/j.ymthe.2005.11.022. Epub 2006 Feb 15. Mol Ther. 2006. PMID: 16480930 Free article. Clinical Trial.
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D. Sonpavde G, et al. Among authors: miles bj. Clin Cancer Res. 2011 Nov 15;17(22):7174-82. doi: 10.1158/1078-0432.CCR-11-1899. Epub 2011 Sep 20. Clin Cancer Res. 2011. PMID: 21933889 Free PMC article. Clinical Trial.
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.
Teh BS, Aguilar-Cordova E, Kernen K, Chou CC, Shalev M, Vlachaki MT, Miles B, Kadmon D, Mai WY, Caillouet J, Davis M, Ayala G, Wheeler T, Brady J, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Butler EB. Teh BS, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):605-13. doi: 10.1016/s0360-3016(01)01692-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11597799 Clinical Trial.
164 results